GlassScriptPhysician profile
Kristin E Wagner
NPI 1518943166
$1,667.02
in general payments reported to CMS, 2019-2025
28 companies · $402 in 2025
The $402 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.63 · 2020: $110 · 2021: $60.76 · 2022: $288 · 2023: $343 · 2024: $368 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $515.12 | 2019-2025 | Synthroid |
| Corcept Therapeutics | $144.43 | 2023-2025 | Korlym |
| Lemaitre Vascular, INC. | $137.00 | 2022-2024 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
| Amneal Pharmaceuticals LLC | $113.96 | 2022-2024 | Unithroid |
| Endologix LLC | $88.92 | 2022-2024 | Ovation Ix Iliac Stent Graft, Afx2 Bifurcated Endograft System, Torus Stent Graft System |
| Medtronic, INC. | $87.24 | 2024-2025 | Nim Vital, Pteye Parathyroid Detection System |
| Sanara Medtech INC. | $74.38 | 2023-2025 | Celleraterx, Celleraterx |
| Cordis US Corp. | $58.36 | 2025 | Mynx Control Venous, Mynx Control |
| Abbott Laboratories | $55.26 | 2024 | Esprit |
| Integra Lifesciences Corporation | $42.14 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Surmodics, INC. | $40.80 | 2023 | Pounce Thrombectomy System |
| Bolton Medical INC | $31.27 | 2025 | Treo Abdominal Stent-Graft System |
| Smith+Nephew, INC. | $27.36 | 2024 | Stravix |
| Merck Sharp & Dohme LLC | $23.96 | 2022 | |
| Haemonetics Corporation | $22.53 | 2023 | Teg6s Hemostasis System |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $22.06 | 2022 | |
| Stryker Corporation | $20.66 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Olympus America INC. | $18.58 | 2020 | |
| Innocoll Pharmaceuticals Limited | $18.17 | 2022 | |
| Pfizer INC. | $16.89 | 2022 | |
| Davol INC. | $16.42 | 2025 | |
| Mozarc Medical US LLC | $15.92 | 2023 | Argyle |
| Csl Behring | $14.38 | 2019 | |
| Teleflex LLC | $14.06 | 2023 | Weck |
| Janssen Pharmaceuticals, INC | $12.79 | 2023 | Xarelto |
| Biom'Up France Sas | $12.35 | 2020 | |
| Ibsa Pharma INC. | $12.02 | 2019 | |
| Cardiovascular Systems INC. | $9.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.